University of Hertfordshire

Frontiers in Pharmacology

ISSNs: 1663-9812

Frontiers Media S.A.

Scopus rating (2021): CiteScore 6.6 SJR 1.143 SNIP 1.388

Indexed in DOAJ

Journal

  1. 2022
  2. Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement

    Ngum, N., Mashingia, J., Ndomondo-Sigonda, M., Walker, S. & Salek, S., 3 Nov 2022, (E-pub ahead of print) In: Frontiers in Pharmacology. 13, 1031289.

    Research output: Contribution to journalArticlepeer-review

  3. Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain

    Lione, L. A. & Fisher, A., 15 Sep 2022, (E-pub ahead of print) In: Frontiers in Pharmacology. 13, 2 p.

    Research output: Contribution to journalEditorialpeer-review

  4. Exploring neuroinflammatory pathways that contribute to chronic pain

    Lione, L. & Fisher, A., 15 Sep 2022, In: Frontiers in Pharmacology. p. 1-2 2 p.

    Research output: Contribution to journalEditorialpeer-review

  5. Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward

    Ngum, N., Mashingia, J., Ndomondo-Sigonda, M., Walker, S. & Salek, S., 5 Jul 2022, (E-pub ahead of print) In: Frontiers in Pharmacology. 13, 12 p., 891506.

    Research output: Contribution to journalArticlepeer-review

  6. 2021
  7. Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices

    Rahalkar, H., Sheppard, A. & Salek, S., 9 Aug 2021, (E-pub ahead of print) In: Frontiers in Pharmacology. 12, 711361.

    Research output: Contribution to journalArticlepeer-review

  8. South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access

    Keyter, A., Salek, S., Danks, L., Nkambule, P., Semete-Makokotlela, B. & Walker, S., 23 Jul 2021, (E-pub ahead of print) In: Frontiers in Pharmacology. 12, 699063.

    Research output: Contribution to journalArticlepeer-review

  9. Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research: Translatable and Bidirectional Research

    Fisher, A., Lanigan, M., Upton, N. & Lione, L., 8 Feb 2021, In: Frontiers in Pharmacology. 11, 21 p., 614990.

    Research output: Contribution to journalReview articlepeer-review

  10. 2020
  11. Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity

    Goswami, P., Oliva, E., Ionova, T., Else, R., Kell, J., Fielding, AK., Jennings, DM., Karakantza, M., Al-Ismail, S., Collins, GP., McConnell, S., Langton, C. & Salek, S., 5 Mar 2020, In: Frontiers in Pharmacology. 11, p. 209 209.

    Research output: Contribution to journalArticlepeer-review

  12. 2019
  13. Factors influencing delays in patient access to new medicines in Canada: a retrospective study of reimbursement processes in public drug plans

    Salek, M-S. S., Hoskyn, S. L., Johns, J., Allen, N. & Sehgal, C., 29 Mar 2019, In: Frontiers in Pharmacology. 10, 13 p., 196.

    Research output: Contribution to journalArticlepeer-review

  14. The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland

    Keyter, A., Salek, M-S. S., Banoo, S. & Walker, S. R., 14 Mar 2019, In: Frontiers in Pharmacology. 10, p. 1-11 11 p., 228.

    Research output: Contribution to journalArticlepeer-review

  15. Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications

    Salek, M-S. S., Hoskyn, S. L., Johns, J., Allen, N. & Sehgal, C., 18 Feb 2019, In: Frontiers in Pharmacology. 9, p. 1-17 17 p., 1578.

    Research output: Contribution to journalArticlepeer-review

  16. Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems

    Schifano, F., Chiappini, S., Corkery, J. & Guirguis, A., 1 Feb 2019, In: Frontiers in Pharmacology. 10, FEB, p. 1-10 10 p., 46.

    Research output: Contribution to journalArticlepeer-review

  17. 2018
  18. The South African Regulatory System: Past, Present, and Future

    Keyter, A., Banoo, S., Salek, M-S. S. & Walker, S. R., 4 Dec 2018, In: Frontiers in Pharmacology. 9, 13 p., 1407.

    Research output: Contribution to journalArticlepeer-review

  19. Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service

    Dawoud, D. M., Wonderling, D., Glen, J., Lewis, S., Griffin, X., Hunt, B. J., Stansby, G., Reed, M., Rossiter, N., Chahal, J., Sharpin, C. & Barry, P., 27 Nov 2018, In: Frontiers in Pharmacology. 9, NOV, 1370.

    Research output: Contribution to journalArticlepeer-review

  20. Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines

    Rahalkar, H., Cetintas, H. C. & Salek, M-S. S., 28 Sep 2018, In: Frontiers in Pharmacology. 9, 17 p., 1079.

    Research output: Contribution to journalReview articlepeer-review

  21. Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer

    Kosgodage, U. S., Mould, R., Henley, A., Nunn, A., Guy, G., Thomas, E. L., Inal, J., Bell, J. & Lange, S., 13 Aug 2018, In: Frontiers in Pharmacology. 9, AUG, 889.

    Research output: Contribution to journalArticlepeer-review

  22. Is there a potential of misuse for venlafaxine and bupropion?

    Schifano, F. & Chiappini, S., 21 Mar 2018, In: Frontiers in Pharmacology. 9, 10 p., 239.

    Research output: Contribution to journalArticlepeer-review

  23. 2017
  24. A comparison of reimbursement recommendations by European HTA agencies: Is there opportunity for further alignment?

    Allen, N., Liberti, L., Walker, S. R. & Salek, S., 30 Jun 2017, In: Frontiers in Pharmacology. 8, JUN, p. 1-14 14 p., 384.

    Research output: Contribution to journalArticlepeer-review

  25. Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature.

    Bujar, M., McAuslane, N., Walker, S. & Salek, M-S. S., 10 Apr 2017, In: Frontiers in Pharmacology. 10, 8, 189.

    Research output: Contribution to journalArticlepeer-review

  26. 2016
  27. The Development and Validation of a Generic Instrument, QoDoS, for Assessing the Quality of Decision Making.

    Donelan, R., Walker, S. & Salek, M-S. S., 13 Jul 2016, In: Frontiers in Pharmacology. 7, 10 p., 180.

    Research output: Contribution to journalArticlepeer-review

  28. 2015
  29. A practical approach to communicating benefit-risk decisions of medicines to stakeholders.

    Leong, J., Walker, S. & Salek, M-S. S., 11 Jun 2015, In: Frontiers in Pharmacology. 6, p. 1-9 9 p., 99.

    Research output: Contribution to journalArticlepeer-review

  30. 2012
  31. Do patient-reported outcomes have a role in the management of patients with cystic fibrosis?

    Salek, M. S., Rezaie, M., Davies, C., Mills, R. & Ketchell, R. I., 12 Mar 2012, In: Frontiers in Pharmacology. 3, 38.

    Research output: Contribution to journalArticlepeer-review